{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:02:14Z","timestamp":1790521334839,"version":"4.1.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T00:00:00Z","timestamp":1301011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017924","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T20:52:25Z","timestamp":1301086345000},"page":"e17924","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth"],"prefix":"10.1371","volume":"6","author":[{"given":"Vera","family":"Chesnokova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Zonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Ben-Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolja","family":"Wawrowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunguang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalman","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Scheithauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1012945129981","article-title":"Classification of pituitary adenomas.","volume":"54","author":"K Kovacs","year":"2001","journal-title":"J Neurooncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).","volume":"72","author":"A Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for pituitary tumorigenesis: the plastic pituitary.","volume":"112","author":"S Melmed","year":"2003","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","article-title":"Pathobiology of pituitary adenomas and carcinomas.","volume":"59","author":"BW Scheithauer","year":"2006","journal-title":"Neurosurgery"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1172\/JCI20761","article-title":"Telomeres, stem cells, senescence, and cancer.","volume":"113","author":"NE Sharpless","year":"2004","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0955-0674(00)00278-7","article-title":"Putting the stress on senescence.","volume":"13","author":"M Serrano","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.","volume":"88","author":"M Serrano","year":"1997","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi.","volume":"436","author":"C Michaloglou","year":"2005","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/436642a","article-title":"Tumour biology: senescence in premalignant tumours.","volume":"436","author":"M Collado","year":"2005","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature03841","article-title":"Oncogene-induced senescence as an initial barrier in lymphoma development.","volume":"436","author":"M Braig","year":"2005","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1101\/gad.1971610","article-title":"The essence of senescence.","volume":"24","author":"T Kuilman","year":"2010","journal-title":"Genes Dev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1073\/pnas.86.18.7123","article-title":"Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.","volume":"86","author":"DE Jenne","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0014-5793(92)80330-J","article-title":"SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges.","volume":"297","author":"L Kirszbaum","year":"1992","journal-title":"FEBS Lett"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/0008-5472.CAN-08-2912","article-title":"Advances and challenges in basic and translational research on clusterin.","volume":"69","author":"IP Trougakos","year":"2009","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/0008-5472.CAN-04-2077","article-title":"Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.","volume":"64","author":"T Chen","year":"2004","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/ERC-09-0140","article-title":"The clusterin paradigm in prostate and breast carcinogenesis.","volume":"17","author":"F Rizzi","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1038\/onc.2009.286","article-title":"Genetic inactivation of ApoJ\/clusterin: effects on prostate tumourigenesis and metastatic spread.","volume":"28","author":"S Bettuzzi","year":"2009","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jnci\/djp063","article-title":"Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.","volume":"101","author":"O Chayka","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/ATVBAHA.109.190058","article-title":"Protective role of clusterin\/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.","volume":"29","author":"HJ Kim","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1067\/mva.2001.116301","article-title":"Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells.","volume":"34","author":"N Sivamurthy","year":"2001","journal-title":"J Vasc Surg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/0008-5472.CAN-03-1953","article-title":"Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo.","volume":"64","author":"A Thomas-Tikhonenko","year":"2004","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1210\/jcem.84.2.5432","article-title":"Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.","volume":"84","author":"X Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1677\/ERC-08-0012","article-title":"Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.","volume":"15","author":"F Salehi","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2265.2006.02630.x","article-title":"Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.","volume":"65","author":"M Filippella","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/mend.11.4.9911","article-title":"Isolation and characterization of a pituitary tumor-transforming gene (PTTG).","volume":"11","author":"L Pei","year":"1997","journal-title":"Mol Endocrinol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/er.2006-0042","article-title":"Pituitary tumor-transforming gene: physiology and implications for tumorigenesis.","volume":"28","author":"G Vlotides","year":"2007","journal-title":"Endocr Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/15275","article-title":"Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.","volume":"5","author":"AP Heaney","year":"1999","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/me.2004-0403","article-title":"Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice.","volume":"19","author":"RA Abbud","year":"2005","journal-title":"Mol Endocrinol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10564","DOI":"10.1158\/0008-5472.CAN-07-0974","article-title":"Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.","volume":"67","author":"V Chesnokova","year":"2007","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1126\/science.285.5426.418","article-title":"Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.","volume":"285","author":"H Zou","year":"1999","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1210\/mend.15.11.0729","article-title":"Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division.","volume":"15","author":"Z Wang","year":"2001","journal-title":"Mol Endocrinol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"22630","DOI":"10.1074\/jbc.M109.096255","article-title":"Overexpression of the pituitary tumor transforming gene induces p53-dependent senescence through activating DNA damage response pathway in normal human fibroblasts.","volume":"285","author":"YH Hsu","year":"2010","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.cdd.4402254","article-title":"Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin.","volume":"15","author":"JA Bernal","year":"2008","journal-title":"Cell Death Differ"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.0804810105","article-title":"p21(Cip1) restrains pituitary tumor growth.","volume":"105","author":"V Chesnokova","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/me.2005-0303","article-title":"FOXL2 in the pituitary: molecular, genetic, and developmental analysis.","volume":"20","author":"BS Ellsworth","year":"2006","journal-title":"Mol Endocrinol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ncb1095","article-title":"Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks.","volume":"6","author":"OA Sedelnikova","year":"2004","journal-title":"Nat Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8747","DOI":"10.1158\/0008-5472.CAN-05-1471","article-title":"ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development.","volume":"65","author":"KC Shen","year":"2005","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1210\/en.2006-0544","article-title":"Pituitary tumor transforming gene overexpression facilitates pituitary tumor development.","volume":"147","author":"I Donangelo","year":"2006","journal-title":"Endocrinology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8726","DOI":"10.1158\/0008-5472.CAN-09-0729","article-title":"p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage.","volume":"69","author":"M Cuadrado","year":"2009","journal-title":"Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging.","volume":"130","author":"M Collado","year":"2007","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation.","volume":"365","author":"DP Ramji","year":"2002","journal-title":"Biochem J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tcb.2007.07.004","article-title":"The C\/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control.","volume":"17","author":"C Nerlov","year":"2007","journal-title":"Trends Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.onc.1208393","article-title":"C\/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.","volume":"24","author":"S Gery","year":"2005","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","article-title":"Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.","volume":"113","author":"M Narita","year":"2003","journal-title":"Cell"},{"key":"ref45","first-page":"1","article-title":"Expression of FOXL2 in human normal pituitaries and pituitary adenomas.","author":"N Egashira","year":"2010","journal-title":"Modern Pathology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"pe69","DOI":"10.1126\/stke.4152007pe69","article-title":"Nuclear localization of growth hormone receptor: another age of discovery for cytokine action?","volume":"2007","author":"SM Swanson","year":"2007","journal-title":"Sci STKE"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/MCB.00848-09","article-title":"Frequency-dependent regulation of follicle-stimulating hormone beta by pulsatile gonadotropin-releasing hormone is mediated by functional antagonism of bZIP transcription factors.","volume":"30","author":"NA Ciccone","year":"2010","journal-title":"Mol Cell Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/er.2008-0022","article-title":"Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.","volume":"30","author":"DL Kleinberg","year":"2009","journal-title":"Endocr Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","article-title":"Prolactin: the new biology of an old hormone.","volume":"64","author":"V Goffin","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1073\/pnas.0914261107","article-title":"Salt bridge integrates GPCR activation with protein trafficking.","volume":"107","author":"JA Janovick","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrc2560","article-title":"Senescence-messaging secretome: SMS-ing cellular stress.","volume":"9","author":"T Kuilman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1242\/dev.02050","article-title":"C\/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution.","volume":"132","author":"M Thangaraju","year":"2005","journal-title":"Development"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1101\/gad.5.9.1538","article-title":"Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3-L1 cells.","volume":"5","author":"Z Cao","year":"1991","journal-title":"Genes Dev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jcp.21671","article-title":"Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells.","volume":"219","author":"F Rizzi","year":"2009","journal-title":"J Cell Physiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0303-7207(01)00477-4","article-title":"Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15\/INK4B.","volume":"176","author":"SJ Frost","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/13543780802528609","article-title":"Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer.","volume":"17","author":"KN Chi","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2407-10-107","article-title":"Effects of clusterin over-expression on metastatic progression and therapy in breast cancer.","volume":"10","author":"L Flanagan","year":"2010","journal-title":"BMC Cancer"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cellsig.2009.01.008","article-title":"Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK\/Slug pathway.","volume":"21","author":"TY Chou","year":"2009","journal-title":"Cell Signal"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"14212","DOI":"10.1074\/jbc.M412569200","article-title":"Delayed activation of insulin-like growth factor-1 receptor\/Src\/MAPK\/Egr-1 signaling regulates clusterin expression, a pro-survival factor.","volume":"280","author":"T Criswell","year":"2005","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1038\/sj.onc.1205594","article-title":"Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression.","volume":"21","author":"S Bettuzzi","year":"2002","journal-title":"Oncogene"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-230X(09)05004-0","article-title":"Clusterin (CLU) and lung cancer.","volume":"105","author":"F Panico","year":"2009","journal-title":"Adv Cancer Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-437X(01)00259-3","article-title":"TGF-beta signaling: positive and negative effects on tumorigenesis.","volume":"12","author":"LM Wakefield","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/0008-5472.CAN-08-0206","article-title":"Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.","volume":"68","author":"JS Nam","year":"2008","journal-title":"Cancer Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1242\/dev.122.10.3319","article-title":"Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice.","volume":"122","author":"ET Alarid","year":"1996","journal-title":"Development"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:50:35Z","timestamp":1637434235000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017924"}},"subtitle":[],"editor":[{"given":"Alfredo","family":"Fusco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,25]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017924","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,25]]}}}